April 17, 2020 SC Labs

Cannabis Inflorescence for Medical Purposes: USP Considerations for Quality Attributes

Just in time for 420, we have what may be the most important step yet towards an international standard for quality and purity in cannabis. On Monday, the United States Pharmacopeial Convention (USP) published a paper titled “Cannabis Inflorescence for Medical Purposes: USP Considerations for Quality Attributes” in the Journal of Natural Products and according to the paper, “The principles outlined in this review should be able to be used as the basis of public quality specification for cannabis inflorescence (flowers)…”

Our President, Josh Wurzer, has been serving for several years as an independent expert on the USP’s Cannabis Expert Panel and is one of the co-authors of the paper. SC Labs was proud to be able to contribute data as well as our test methodology to the effort.

Standards published by the USP for drugs, dietary supplements, or food, when published in either the USP-NF or Food Chemicals Codex, are recognized by US federal law and, in some cases, internationally. This paper is the first step towards similar recognition of a unified set of cannabis standards by the federal government.

The principles outlined in this review should be able to be used as the basis of public quality specification for cannabis inflorescence (flowers)

Download full manuscript at USP.org

SC Labs

Are you over 21 years of age?

Your current browser is unsupported. Please install latest version of Firefox, Chrome or IE to view this site.